Add this topic to your myFT Digest for news straight to your inbox
Drugmaker’s shares plunge on fears osteoporosis medication will not win approval
Belgian group discovers bone-rebuilding treatment in South Africa
US stocks broadly advance amid a rally in global markets
Generics sale highlights growth of ‘precision M&A’
Merck and UCB highlight the plight of some pharma companies
Rob Hardy believes Aesica’s success proves British manufacturing can thrive
SMEs are spearheading the growth of new industries, finds Simon Mee
Biotech is being targeted to develop existing expertise, says Simon Mee
Dutch insurer Aegon climbs 3.2 per cent
SAP weakens after management reshuffle
International Edition